On the 9th of June we teamed up with the Major Mouse Testing Program (MMTP) for a live stream longevity panel on the MMTP Facebook page. The panel included Dr. Alexandra Stolzing, Dr. Aubrey de Grey, Dr. Oliver Medvedik, MMTP coordinators Steve Hill and Elena Milova, Lifespan.io President Keith Comito, and one of the most…

LEAF/Lifespan.io is teaming up with the Major Mouse Testing Program (MMTP) for a special longevity panel with Dr. Alexandra Stolzing, Dr. Aubrey de Grey, Dr. Oliver Medvedik and a number of guests. The MMTP will be streaming the panel live to their Facebook page and we invite you to join us. The panel will also…

Here at LEAF we have been busy advocating for rejuvenation biotechnology. Elena Milova recently attended the first International Longevity and Cryopreservation Summit in Madrid, with a talk about how to deliver the most effective messages to engage the general public to support aging and rejuvenation research. We will shortly have a number of exciting articles…

The removal of senescent cells has shown further potential for the treatment of osteoarthritis in this recent publication where the researchers reduce the impact of post injury osteoarthritis by clearing senescent cells[1]. As we have discussed many times in our publications, senescent cells are a key player in the aging process, if you are new…

The SENS Research Foundation has announced a collaboration with the Buck institute for Research on Aging. The two foundations have collaborated a great deal in the past and the focus of this new research is to be work on cellular senescence in relation to the age-related decline of the immune system. This research was made possible through…

New medical technologies need bold researchers to make the leap from the laboratory table to hospitals and clinics where they can improve or even save lives. Kelsey Moody, a 30-year-old scientist from Beekmantown, is one such researcher. Kelsey is especially interested in the treatment of age-related diseases but using a different approach. Currently researching age-related…

The development pipeline for new drugs and therapies is a long one, and on average it can take up to 17 years to research, test and bring a new product to market [1]. The reasons for this are myriad and complex, the demanding test phases required for safety and efficacy, the preclinical tests, the regulatory…

For many of you reading this article Dr Aubrey de Grey, needs little or no introduction. However, for those less well acquainted with his work, he is one of the most prominent scientists in the field of rejuvenation biotechnology. More than fifteen years ago, Aubrey took up the challenge of persuading the aging research community, that…

We are testing a diverse drug library to find treatments for ‘ALT’ cancers, those which rely on…

At the SENS Research Foundation, we are working on creating an innovative system to repair…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD